Cytonet, Promethera deal

Promethera acquired Cytonet’s “key” assets, including Heparesc. Promethera also will receive a U.S. Cytonet facility in Durham, North Carolina, with a team of 18 people for organ and tissue processing, product manufacturing and liver sourcing with a U.S. organ procurement organization. A team of seven Cytonet employees will be added to Promethera’s Belgian headquarters. ...